Chenghe Acquisition III
CHEC · NASDAQ
About CHEC
- Employees
- 0
- Listed
- Sep 16, 2025
- Sector
- N/A
- Industry
- N/A
- Website
- chengheinv.com
CHEC key statistics
- Market cap
- 177.76M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 33.88K
- Volume
- 11.02K
- Open price
- $10.34
- High today
- $10.29
- Low today
- $10.28
- 52 Week high
- $10.56
- 52 Week low
- $9.91
Chenghe Acquisition III (CHEC) at a glance
Chenghe Acquisition III (CHEC) last traded at $10.29, with a market cap of 177.76M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $10.28 and $10.29. The current price is 0.1% above the day's low and 0.0% below its high.
Volume so far is 11.02K shares, below the average of 33.88K shares a day.
Over the past year Chenghe Acquisition III has ranged from $9.91 to $10.56, and now sits 58% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- RDARRaadr$0.0002−16.67%
- AXGSolowin Holdings$0.04−25.65%
- AEFIAmerican EcoFuels$0.0009+12.50%
- SHFSSHF Holdings$0.1158+23.19%
- DVLTDatavault AI$0.067−49.55%
- MASNMaison Luxe$0.0002+0.00%
- XXII22nd Century Group$0.1048+18.55%
- NBNDNetBrands$0.0007+0.00%
- NEXRNexera Technologies$0.5454+21.77%
- TIPSTianrong Internet Products & Services$0.0011+57.14%
- AITXArtificial Intelligence Technology Solutions$0.0008−20.00%
Newly listed
Companies that went public in the past six weeks
- LYCALycia Therapeutics$26.11−9.50%
- DAVIDAVION HEALTHCARE$3.00−26.29%
- TCXBTCGX Acquisition Corp. II$10.28+0.10%
- CTYCITY THERAPEUTICS$20.86+0.34%
- IAMIambic Therapeutics$14.00−2.85%
- AMROAmaero$6.04+12.48%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.23−0.49%
- TRXBTRex Bio$13.79−0.58%
- RTSNRetension Pharmaceuticals$13.52−5.06%
- PAXGUPine Tree Acquisition$10.00−0.20%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.20+1.36%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.